These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23817654)

  • 21. [Therapy ofrary tct infections with Nicene (a quinoline--sulfanilamide preparation)].
    Metz H; Flogaus K
    Munch Med Wochenschr; 1969 Oct; 111(41):2099-102. PubMed ID: 4900861
    [No Abstract]   [Full Text] [Related]  

  • 22. Empirical treatment of urinary tract infections.
    Leibovici L
    Isr Med Assoc J; 2000 Oct; 2(10):804-5. PubMed ID: 11344744
    [No Abstract]   [Full Text] [Related]  

  • 23. [Spectrum of pathogens and resistance to antibiotics in urinary tract infections and the consequences for antibiotic treatment: study of urology inpatients with urinary tract infections (1994-2001)].
    Wagenlehner E; Niemetz A; Naber G
    Urologe A; 2003 Jan; 42(1):13-25. PubMed ID: 12574879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance.
    Gualco L; Schito AM; Schito GC; Marchese A
    Int J Antimicrob Agents; 2007 Jun; 29(6):679-87. PubMed ID: 17363225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of levofloxacin susceptibility against strains isolated from lower urinary tract infections in the community].
    Weber P; Dib C; Durand C; Moniot-Ville N
    Pathol Biol (Paris); 2005 Mar; 53(2):125-8. PubMed ID: 15708658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary tract infections and a multidrug-resistant Escherichia coli clonal group.
    Sandel DC; Wang CT; Kessler S
    N Engl J Med; 2002 Feb; 346(7):535-6. PubMed ID: 11844861
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical evaluation of lividomycin in urinary tract infections].
    Tokito T; Shigematsu S; Eto K
    Jpn J Antibiot; 1972 Dec; 25(6):432-5. PubMed ID: 4579564
    [No Abstract]   [Full Text] [Related]  

  • 28. Economic evaluation of an updated guideline for the empiric treatment of uncomplicated urinary tract infection in women.
    Berger RE
    J Urol; 2005 Nov; 174(5):1841. PubMed ID: 16217304
    [No Abstract]   [Full Text] [Related]  

  • 29. An epidemic of urinary tract infections?
    Stamm WE
    N Engl J Med; 2001 Oct; 345(14):1055-7. PubMed ID: 11586959
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
    Brown PD; Freeman A; Foxman B
    Clin Infect Dis; 2002 Apr; 34(8):1061-6. PubMed ID: 11914994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitrofurantoin: the return of an old friend in the wake of growing resistance.
    Arya SC; Agarwal N
    BJU Int; 2009 Apr; 103(7):994-5. PubMed ID: 19302136
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prescriptions of a new antibiotic following treatment with sulfamethizole or pivmecillinam].
    Bjerrum L; Dessau RB; Hallas J
    Ugeskr Laeger; 2003 Sep; 165(39):3732-5. PubMed ID: 14558387
    [No Abstract]   [Full Text] [Related]  

  • 33. [Urinary tract infections in outpatients treated in 2002-2003].
    Luczak M; Rokosz A; Wachnik A; Kamola R; Stypułkowska A
    Przegl Lek; 2005; 62(2):81-5. PubMed ID: 16095149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate.
    Lagacé-Wiens PR; Nichol KA; Nicolle LE; DeCorby M; McCracken M; Mulvey MR; Zhanel GG
    J Antimicrob Chemother; 2006 Jun; 57(6):1262-3. PubMed ID: 16565157
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro study of the susceptibility of Escherichia coli to mecillinam.
    Bjerager L; Skov R; Frimodt-Møller N
    J Antimicrob Chemother; 2000 Jun; 45(6):920-1. PubMed ID: 10837453
    [No Abstract]   [Full Text] [Related]  

  • 36. Utilization of fluoroquinolones and Escherichia coli resistance in urinary tract infection: inpatients and outpatients.
    Urbánek K; Kolár M; Strojil J; Koukalová D; Cekanová L; Hejnar P
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):741-5. PubMed ID: 15880441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Combination of trimethoprim and sulfamethoxazole in coliform urinary infections].
    Langlois Y; Mélançon J; Tétreault L
    Union Med Can; 1973 Feb; 102(2):395-9. PubMed ID: 4575499
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical evaluation of cephalexin monohydrate in the treatment of infections of the genitourinary system].
    Aspe AJ
    Prensa Med Mex; 1970; ():45-50. PubMed ID: 4931116
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapeutic strategies involving antimicrobial treatment of the canine urinary tract.
    Ling GV
    J Am Vet Med Assoc; 1984 Nov; 185(10):1162-4. PubMed ID: 6392247
    [No Abstract]   [Full Text] [Related]  

  • 40. Effective treatment of urinary tract infections.
    Acar JF
    Infection; 1980; Suppl 1():70-4. PubMed ID: 6772580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.